Sahar Emami Naeini

This study investigates how vascular dysfunction in VCID affects innate immune cells, finding compartment-specific ILC redistribution and pro-inflammatory neutrophil polarization in the brain.

This study identifies a neuro-immune-microbiome axis in glioblastoma that can be targeted by intranasal cannabidiol to reverse tumor progression.

This study investigates whether inhaled CBD pretreatment inhibits GBM growth in mice, finding that 14-day pretreatment reduces tumor growth and modulates the immune microenvironment.

This study shows that ILC2s can cross the BBB and home to glioblastoma tumors in mice, supporting adoptive transfer as a potential strategy for targeting CNS tumors.

This study shows that chronic nicotine pouch exposure worsens seizures and glymphatic function in mice, but inhaled CBD reverses these effects.

This study investigates how cannabidiol affects IDO and cGAS pathways in Alzheimer's disease using a mouse model, finding reduced inflammation and cytokine levels.

This study evaluates the effectiveness of different CBD formulations and delivery routes in reducing seizure severity in a mouse model of epilepsy, finding inhaled broad-spectrum CBD to be most effective.

This study investigates whether inhaled cannabidiol (CBD) can reverse fentanyl addiction and modulate neuroinflammation in a mouse model.

This study shows that combining cannabidiol and probiotics reduces glycemic indicators, improves insulin production, and alleviates type 2 diabetes symptoms in mice.